OpenVSafe by OpenVAERS
Search V-safe

28S-14423-30728

2 vaccinations 1 coded response 23 check-ins 0 free-text entries 0 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
479 / IN
Registered
2022-06-22
Relationship
Child or adolescent in my care
Guardian
UL5-27370-08236
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-22
    Registered in v-safe
  2. 2022-06-25
    Dose 1 — Pfizer-BioNTech
  3. 2022-06-25
    Health check-in — day 0, dose 1, under 3
    Feeling: Fair · Sleepiness
    Under 3 check-in
  4. 2022-06-26
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Sleepiness
    Under 3 check-in
  5. 2022-06-27
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-06-28
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-06-29
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-06-30
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Sleepiness, Loss of appetite
    Under 3 check-in
  9. 2022-07-01
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-07-02
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · Sleepiness
    Under 3 check-in
  11. 2022-07-10
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-07-16
    Dose 2 — Pfizer-BioNTech
  13. 2022-07-16
    Health check-in — day 0, dose 2, under 3
    Feeling: Fair · Site: Pain · Sleepiness
    Under 3 check-in
  14. 2022-07-17
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Site: Pain · Loss of appetite
    Under 3 check-in
  15. 2022-07-18
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Site: Pain · Sleepiness, Diarrhea, Rash, not including the immediate area around the injection site
    Under 3 check-in
  16. 2022-07-19
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Site: Pain · Sleepiness, Irritability/crying, Rash, not including the immediate area around the injection site
    Under 3 check-in
  17. 2022-07-21
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Sleepiness
    Under 3 check-in
  18. 2022-07-22
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Sleepiness, Irritability/crying
    Under 3 check-in
  19. 2022-07-25
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  20. 2022-07-30
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2022-08-07
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  22. 2022-08-13
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2022-08-20
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  24. 2022-08-27
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  25. 2022-10-15
    Health check-in — 3 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  26. 2023-01-14
    Survey response — 6 months, dose 2, under 3
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-06-25Pfizer-BioNTech No
22022-07-16Pfizer-BioNTech No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…